Search

Brenda Libby Coleman

Examiner (ID: 13884, Phone: (571)272-0665 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1202, 2611, 1624, 1611
Total Applications
3154
Issued Applications
1967
Pending Applications
488
Abandoned Applications
741

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18215218 [patent_doc_number] => 11590131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Compositions and methods for treating galactosemia [patent_app_type] => utility [patent_app_number] => 16/634509 [patent_app_country] => US [patent_app_date] => 2018-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 16305 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634509 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/634509
Compositions and methods for treating galactosemia Jul 26, 2018 Issued
Array ( [id] => 16190772 [patent_doc_number] => 20200231621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => CRYSTALLINE OR AMORPHOUS FORM OF STEROID DERIVATIVE FXR AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/633111 [patent_app_country] => US [patent_app_date] => 2018-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8396 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633111 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/633111
Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof Jul 25, 2018 Issued
Array ( [id] => 16190773 [patent_doc_number] => 20200231622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => METHOD FOR PREPARING STEROID DERIVATIVE FXR AGONIST [patent_app_type] => utility [patent_app_number] => 16/633122 [patent_app_country] => US [patent_app_date] => 2018-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633122 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/633122
Method for preparing steroid derivative FXR agonist Jul 25, 2018 Issued
Array ( [id] => 16854862 [patent_doc_number] => 20210155607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => INTERMEDIATES USEFUL FOR THE SYNTHESIS OF A SELECTIVE INHIBITOR AGAINST PROTEIN KINASE AND PROCESSES FOR PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 16/633756 [patent_app_country] => US [patent_app_date] => 2018-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633756 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/633756
Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same Jul 24, 2018 Issued
Array ( [id] => 17286245 [patent_doc_number] => 11202783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-21 [patent_title] => Use of aminoalkylbenzothiazepine derivatives [patent_app_type] => utility [patent_app_number] => 16/631611 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4426 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631611 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/631611
Use of aminoalkylbenzothiazepine derivatives Jul 19, 2018 Issued
Array ( [id] => 17496458 [patent_doc_number] => 11285141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Composition and methods for the treatment of myopia [patent_app_type] => utility [patent_app_number] => 16/632105 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10846 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632105 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632105
Composition and methods for the treatment of myopia Jul 19, 2018 Issued
Array ( [id] => 13536531 [patent_doc_number] => 20180319809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/039877 [patent_app_country] => US [patent_app_date] => 2018-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039877 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/039877
Fused quadracyclic compounds, compositions and uses thereof Jul 18, 2018 Issued
Array ( [id] => 15927867 [patent_doc_number] => 20200155567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY [patent_app_type] => utility [patent_app_number] => 16/630103 [patent_app_country] => US [patent_app_date] => 2018-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630103 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630103
TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY Jul 16, 2018 Abandoned
Array ( [id] => 13504611 [patent_doc_number] => 20180303848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => SUBSTITUTED TRIAZOLOBENZODIAZEPINES [patent_app_type] => utility [patent_app_number] => 16/025512 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025512 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/025512
Substituted triazolobenzodiazepines Jul 1, 2018 Issued
Array ( [id] => 15293405 [patent_doc_number] => 20190389838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => BENZAZEPINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/480842 [patent_app_country] => US [patent_app_date] => 2018-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480842 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480842
Benzazepine derivatives Jun 28, 2018 Issued
Array ( [id] => 16985438 [patent_doc_number] => 11072594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-27 [patent_title] => Trioxolane agents [patent_app_type] => utility [patent_app_number] => 16/625237 [patent_app_country] => US [patent_app_date] => 2018-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 63886 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625237 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/625237
Trioxolane agents Jun 26, 2018 Issued
Array ( [id] => 13504547 [patent_doc_number] => 20180303816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => SALTS AND COMPOSITIONS USEFUL FOR TREATING DISEASE [patent_app_type] => utility [patent_app_number] => 16/019265 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/019265
SALTS AND COMPOSITIONS USEFUL FOR TREATING DISEASE Jun 25, 2018 Abandoned
Array ( [id] => 15963075 [patent_doc_number] => 20200165289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF OBETICHOLIC ACID AND DERIVATIVES THEREOF [patent_app_type] => utility [patent_app_number] => 16/632304 [patent_app_country] => US [patent_app_date] => 2018-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10581 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632304 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632304
Process and intermediates for the synthesis of obeticholic acid and derivatives thereof Jun 21, 2018 Issued
Array ( [id] => 14684817 [patent_doc_number] => 20190241523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => THERAPEUTIC COMPOUNDS AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/010717 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010717 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/010717
THERAPEUTIC COMPOUNDS AND COMPOSITIONS Jun 17, 2018 Abandoned
Array ( [id] => 18003484 [patent_doc_number] => 20220362250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY [patent_app_type] => utility [patent_app_number] => 16/619526 [patent_app_country] => US [patent_app_date] => 2018-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619526 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/619526
Methods of treating brain tumors using combination therapy Jun 11, 2018 Issued
Array ( [id] => 15383641 [patent_doc_number] => 10532992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Prodrugs of urolithins and uses thereof [patent_app_type] => utility [patent_app_number] => 16/005160 [patent_app_country] => US [patent_app_date] => 2018-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8861 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005160 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/005160
Prodrugs of urolithins and uses thereof Jun 10, 2018 Issued
Array ( [id] => 14883405 [patent_doc_number] => 10421728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Peptide nucleic acid monomer and a preparation method [patent_app_type] => utility [patent_app_number] => 16/003304 [patent_app_country] => US [patent_app_date] => 2018-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3077 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003304 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/003304
Peptide nucleic acid monomer and a preparation method Jun 7, 2018 Issued
Array ( [id] => 15827095 [patent_doc_number] => 20200128829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => Antimicrobial Compounds [patent_app_type] => utility [patent_app_number] => 16/619555 [patent_app_country] => US [patent_app_date] => 2018-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619555 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/619555
Antimicrobial Compounds Jun 6, 2018 Abandoned
Array ( [id] => 16799033 [patent_doc_number] => 10993948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => RNA polymerase I inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 15/996544 [patent_app_country] => US [patent_app_date] => 2018-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 25064 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996544 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/996544
RNA polymerase I inhibitors and uses thereof Jun 3, 2018 Issued
Array ( [id] => 17697052 [patent_doc_number] => 11370762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Vinylarene derivative and application [patent_app_type] => utility [patent_app_number] => 16/489815 [patent_app_country] => US [patent_app_date] => 2018-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19761 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489815 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489815
Vinylarene derivative and application May 30, 2018 Issued
Menu